Apeiron Biologics Establishes Biotech-Spinoff Attoquant Diagnostics

APEIRON Biologics AG today announced the launch of Attoquant Diagnostics GmbH as a subsidiary. Attoquant will globally commercialize its already successfully marketed peptide analytics service RAS-Fingerprint™ and further develop the underlying platform technology.

Press release

Presseaussendung